Beta-adrenergic augmentation of flecainide-induced conduction slowing in canine Purkinje fibers.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Circulation

• Publication date

  1997-10-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.96.8.2701PMID 9355912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional effects of protein kinase C activation on the human cardiac Na+ channel.

  1997cited by this paper
• Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts.

  1995cited by this paper
• Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs.

  1995cited by this paper
• Interaction of Baseline Characteristics With The Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients With Myocardial Infarction: A Possible Explanation for Increased Mortality in the Cardiac Arrhythmia Suppression Trial (CAST)

  1994cited by this paper
• Voltage-independent effects of extracellular K+ on the Na+ current and phase 0 of the action potential in isolated cardiac myocytes.

  1994cited by this paper
• Modulation of cardiac Na+ channels expressed in a mammalian cell line and in ventricular myocytes by protein kinase C.

  1994cited by this paper
• Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.

  1994cited by this paper
• Beta-blocker therapy in the cardiac arrhythmia suppression trial

  1994cited by this paper
• Voltage dependence of beta-adrenergic modulation of conduction in the canine Purkinje fiber.

  1994cited by this paper
• Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase.

  1993cited by this paper
• Identification of the sites of selective phosphorylation and dephosphorylation of the rat brain Na+ channel alpha subunit by cAMP-dependent protein kinase and phosphoprotein phosphatases.

  1993cited by this paper
• Differential Effects of Isoproterenol on Sustained Ventricular Tachycardia Before and During Procainamide and Quinidine Antiarrhythmic Drug Therapy

  1993cited by this paper
• Mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics.

  1993cited by this paper
• Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells.

  1993cited by this paper
• States and sites of actions of flecainide on guinea-pig cardiac sodium channels.

  1992cited by this paper
• Functional modulation of brain sodium channels by cAMP-dependent phosphorylation.

  1992cited by this paper
• Enhancement of rabbit cardiac sodium channels by beta-adrenergic stimulation.

  1992cited by this paper
• A phosphorylation site in the Na+ channel required for modulation by protein kinase C.

  1991cited by this paper
• Proarrhythmic Effects of Flecainide: Experimental Evidence for Increased Susceptibility to Reentrant Arrhythmias

  1991cited by this paper
• Further studies on the influence of cAMP-dependent protein kinase on junctional conductance in isolated heart cell pairs.

  1991cited by this paper
• Influence of β-adrenergic stimulation on the fast sodium current in the intact rat papillary muscle

  1991cited by this paper
• Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.

  1991cited by this paper
• Flecainide Toxicity: Reversal of Drug Effects by Isoproterenol Infusion

  1991cited by this paper
• Further studies on the influence of cAMP-dependent protein kinase on junctional conductance in isolated heart cell pairs.

  1991cited by this paper
• The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction.

  1990cited by this paper
• Inhibition of cardiac Na+ currents by isoproterenol.

  1990cited by this paper
• Double-wave reentry as a mechanism of acceleration of ventricular tachycardia.

  1990cited by this paper
• Structure-activity relations of the cardiac gap junction channel.

  1990cited by this paper
• Fast and slow blockade of sodium channels by flecainide in rabbit cardiac Purkinje fibres

  1990cited by this paper
• Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery.

  1990cited by this paper
• Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.

  1989cited by this paper
• Effect of isoproterenol and 3-isobutyl-1-methylxanthine on junctional conductance in heart cell pairs.

  1989cited by this paper
• Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.

  1989cited by this paper
• Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.

  1989cited by this paper
• Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias.

  1989cited by this paper
• Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current.

  1989cited by this paper
• Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).

  1989cited by this paper
• Beta-adrenergic inhibition of cardiac sodium channels by dual G-protein pathways.

  1989cited by this paper
• Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

  1989cited by this paper
• Effect of isoproterenol and 3-isobutyl-1-methylxanthine on junctional conductance in heart cell pairs

  1989cited by this paper
• Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.

  1988cited by this paper
• Voltage-dependent effects of isoproterenol on cytosolic Ca concentration in rat heart.

  1987cited by this paper
• Cell pairs isolated from adult guinea pig and rat hearts: effects of [Ca2+]i on nexal membrane resistance

  1987cited by this paper
• Electrophysiological actions of flecainide in normal and infarcted canine Purkinje fibers.

  1985cited by this paper
• Regulation of gap junctional conductance.

  1985cited by this paper
• Isoproterenol inhibits residual fast channel via stimulation of beta-adrenoceptors in guinea-pig ventricular muscle.

  1985cited by this paper
• Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.

  1985cited by this paper
• The Effects of Antiarrhythmic Drugs, Stimulation Frequency, and Potassium‐Induced Resting Membrane: Potential Changes on Conduction Velocity and dV/dtmax in Guinea Pig Myocardium

  1985cited by this paper
• Effect of external potassium and acetylstrophanthidin on conduction velocity of isolated canine Purkinje fibers.

  1985cited by this paper
• pH‐Dependent Effects of Quinidine on the Kinetics of dV/dtmax in Guinea Pig Ventricular Myocardium

  1982cited by this paper
• Effect of Acute Coronary Artery Occlusion on Local Myocardial Extracellular K+ Activity in Swine

  1980cited by this paper
• Myocardial extracellular K+ and H+ increase and noradrenaline release as possible cause of early arrhythmias following acute coronary artery occlusion in pigs.

  1980cited by this paper
• The pH-dependent rate of action of local anesthetics on the node of Ranvier

  1977cited by this paper
• Combined Effects of Rate, Membrane Potential, and Drugs on Maximum Rate of Rise ( Vmax) of Action Potential Upstroke of Guinea Pig Papillary Muscle

  1976cited by this paper
• Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects.

  1974cited by this paper
• Direct release of myocardial catecholamines into the left heart chambers : the enhancing effect of acute coronary occlusion.

  1966cited by this paper

• Digital twinning of the human ventricular activation sequence to Clinical 12-lead ECGs and magnetic resonance imaging using realistic Purkinje networks for in silico clinical trials

  2023cites this paper
• Pro-Arrhythmic Effects of Discontinuous Conduction at the Purkinje Fiber-Ventricle Junction Arising From Heart Failure-Induced Ionic Remodeling – Insights From Computational Modelling

  2022cites this paper
• Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels.

  2022cites this paper
• Estimation of Personalized Minimal Purkinje Systems From Human Electro-Anatomical Maps

  2021cites this paper
• [Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug].

  2018cites this paper
• &bgr;1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of &bgr;-blockers

  2016cites this paper
• Interactions Between Activation And Repolarisation In Predisposition Towards Cardiac Arrhythmia

  2014influential citation
• Biophysically detailed modelling of the pro-arrhythmic effects of heart failure-induced ionic remodelling

  2013cites this paper
• Beta1-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation

  2010cites this paper
• Safety Challenges in the Development of Novel Antiarrhythmic Drugs

  2009cites this paper
• Antiarrhythmic Drug Classification

  2009cites this paper
• Actions of flecainide on susceptibility to phase‐2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts

  2006cites this paper
• Flecainide augments muscle sympathetic nerve activity in humans.

  2002cites this paper
• Simulation study of the effects of flecainide on ventricular muscle cells

  2000cites this paper
• Class IC Antiarrhythmic Drugs, Flecainide and Pilsicainide, Produce ST Segment Elevation Simulating Inferior Myocardial Ischemia

  1998cites this paper